Ken began as a Scientist I with Illumina and spent the next 16 years advancing to the level of Sr. Director. While with Illumina he was involved with a variety of commercial products including the Infinium and Sentrix Gene Expression product lines, as well as NGS applications.
He holds a B.S. in Biochemistry and Molecular Biology, graduating Magna Cum Laude, from Drexel University, and a Ph.D. in Microbiology and Immunology from Stanford University. |